| Dr Donald J Beasley, MD | |
|
8854 W Emerald St Ste 150, Boise, ID 83704-4844 | |
| (208) 229-2368 | |
| (888) 815-1621 |
| Full Name | Dr Donald J Beasley |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 31 Years |
| Location | 8854 W Emerald St Ste 150, Boise, Idaho |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770573750 | NPI | - | NPPES |
| 040013862 | Other | ID | RAILROAD MEDICARE |
| 000010004823 | Other | ID | BLUE SHIELD |
| 000010004824 | Other | ID | BLUE SHIELD |
| DM735 | Other | ID | BLUE CROSS |
| 805241200 | Medicaid | ID | |
| 38117 | Other | ID | BLUE CROSS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | M-7576 (Idaho) | Primary |
| 207Y00000X | Otolaryngology | M7576 (Idaho) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Treasure Valley Hospital | Boise, ID | Hospital |
| St Luke's Wood River Medical Center | Ketchum, ID | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Boise Ent Llc | 2961810213 | 2 |
News Archive
Celladon Corp., a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases, today announced that six-month data from its Phase 2 clinical trial of MYDICAR® show improvements in clinical outcomes and disease markers in advanced heart failure patients treated with the genetically targeted enzyme replacement therapy.
Biomedical engineers at Duke University have recruited an unlikely ally in the fight against the deadliest form of brain cancer - a strain of salmonella that usually causes food poisoning.
Genital warts, commonly caused by human papillomavirus (HPV) are on the decline after routine vaccination of Australian women with a vaccine against HPV. The sexual partners of these women are also beneficiaries of the vaccine.
The Obama administration on Wednesday asked an appeals court for an emergency stay that would lift the ban on federal funding of research involving human embryonic stem cells. U.S. District Judge Royce Lamberth last month ruled that the research violated U.S. law because it involved destroying human embryos, a setback for President Barack Obama who had tried to expand research in hopes it would lead to new cures of diseases.
Scientists are reporting development and successful testing in laboratory mice of a substance that shows promise for becoming the first antidote for cocaine toxicity in humans. According to a report in ACS' journal Molecular Pharmaceutics, the new so-called "passive vaccine" reversed the motor impairment, seizures and other dangerous symptoms of a cocaine overdose, which claims thousands of lives each year among users of the illicit drug.
› Verified 7 days ago
| Entity Name | Saint Alphonsus Regional Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649357716 PECOS PAC ID: 3476462359 Enrollment ID: O20040204001036 |
News Archive
Celladon Corp., a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases, today announced that six-month data from its Phase 2 clinical trial of MYDICAR® show improvements in clinical outcomes and disease markers in advanced heart failure patients treated with the genetically targeted enzyme replacement therapy.
Biomedical engineers at Duke University have recruited an unlikely ally in the fight against the deadliest form of brain cancer - a strain of salmonella that usually causes food poisoning.
Genital warts, commonly caused by human papillomavirus (HPV) are on the decline after routine vaccination of Australian women with a vaccine against HPV. The sexual partners of these women are also beneficiaries of the vaccine.
The Obama administration on Wednesday asked an appeals court for an emergency stay that would lift the ban on federal funding of research involving human embryonic stem cells. U.S. District Judge Royce Lamberth last month ruled that the research violated U.S. law because it involved destroying human embryos, a setback for President Barack Obama who had tried to expand research in hopes it would lead to new cures of diseases.
Scientists are reporting development and successful testing in laboratory mice of a substance that shows promise for becoming the first antidote for cocaine toxicity in humans. According to a report in ACS' journal Molecular Pharmaceutics, the new so-called "passive vaccine" reversed the motor impairment, seizures and other dangerous symptoms of a cocaine overdose, which claims thousands of lives each year among users of the illicit drug.
› Verified 7 days ago
| Entity Name | Boise Ent Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174108674 PECOS PAC ID: 2961810213 Enrollment ID: O20211027002296 |
News Archive
Celladon Corp., a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases, today announced that six-month data from its Phase 2 clinical trial of MYDICAR® show improvements in clinical outcomes and disease markers in advanced heart failure patients treated with the genetically targeted enzyme replacement therapy.
Biomedical engineers at Duke University have recruited an unlikely ally in the fight against the deadliest form of brain cancer - a strain of salmonella that usually causes food poisoning.
Genital warts, commonly caused by human papillomavirus (HPV) are on the decline after routine vaccination of Australian women with a vaccine against HPV. The sexual partners of these women are also beneficiaries of the vaccine.
The Obama administration on Wednesday asked an appeals court for an emergency stay that would lift the ban on federal funding of research involving human embryonic stem cells. U.S. District Judge Royce Lamberth last month ruled that the research violated U.S. law because it involved destroying human embryos, a setback for President Barack Obama who had tried to expand research in hopes it would lead to new cures of diseases.
Scientists are reporting development and successful testing in laboratory mice of a substance that shows promise for becoming the first antidote for cocaine toxicity in humans. According to a report in ACS' journal Molecular Pharmaceutics, the new so-called "passive vaccine" reversed the motor impairment, seizures and other dangerous symptoms of a cocaine overdose, which claims thousands of lives each year among users of the illicit drug.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Donald J Beasley, MD 8854 W Emerald St Ste 150, Boise, ID 83704-4844 Ph: (208) 229-2368 | Dr Donald J Beasley, MD 8854 W Emerald St Ste 150, Boise, ID 83704-4844 Ph: (208) 229-2368 |
News Archive
Celladon Corp., a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases, today announced that six-month data from its Phase 2 clinical trial of MYDICAR® show improvements in clinical outcomes and disease markers in advanced heart failure patients treated with the genetically targeted enzyme replacement therapy.
Biomedical engineers at Duke University have recruited an unlikely ally in the fight against the deadliest form of brain cancer - a strain of salmonella that usually causes food poisoning.
Genital warts, commonly caused by human papillomavirus (HPV) are on the decline after routine vaccination of Australian women with a vaccine against HPV. The sexual partners of these women are also beneficiaries of the vaccine.
The Obama administration on Wednesday asked an appeals court for an emergency stay that would lift the ban on federal funding of research involving human embryonic stem cells. U.S. District Judge Royce Lamberth last month ruled that the research violated U.S. law because it involved destroying human embryos, a setback for President Barack Obama who had tried to expand research in hopes it would lead to new cures of diseases.
Scientists are reporting development and successful testing in laboratory mice of a substance that shows promise for becoming the first antidote for cocaine toxicity in humans. According to a report in ACS' journal Molecular Pharmaceutics, the new so-called "passive vaccine" reversed the motor impairment, seizures and other dangerous symptoms of a cocaine overdose, which claims thousands of lives each year among users of the illicit drug.
› Verified 7 days ago
Mrs. Tiffany Kearny, PA Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 900 N Liberty St Ste 400, Boise, ID 83704 Phone: 208-367-7423 | |
Dr. Eric T Garner, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 900 N Liberty St, Ste 400, Boise, ID 83704 Phone: 208-367-3320 Fax: 208-367-7474 | |
Dr. Jacob G Robison, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 100 E Idaho St, Boise, ID 83712 Phone: 208-381-9590 | |
Dr. Todd Rustad, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 900 N Liberty St, Ste 400, Boise, ID 83704 Phone: 208-367-3320 Fax: 208-367-7474 | |
Tyson Nielsen, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 900 N Liberty St Ste 400, Boise, ID 83704 Phone: 208-367-3320 Fax: 208-267-3979 | |
Bret J Rodgers, Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 6077 N Eagle Rd, Boise, ID 83713 Phone: 208-939-9000 | |
Dr. Ryan Lewis Van De Graaff, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 900 N Liberty St., Ste 400, Boise, ID 83704 Phone: 208-367-3320 Fax: 208-367-7474 |